Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MAX Power Retains New Corporate Secretary
-
Perma-Fix Reports Financial Results and Provides Business Update for Full Year and Fourth Quarter of 2024
-
NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit
-
Driving the Future Together: HP Amplify Conference 2025
-
SUSE Empowers Enterprise Innovation with Expanded Capabilities in SUSE AI
-
Online Fraud is Surging, AI is the Weapon of Choice, Says Veriff's New Report
-
Greenridge Exploration Initiates Airborne MobileMT Survey at the Sabre Uranium Project in Athabasca Basin, Saskatchewan
-
NEXE Innovations Makes Fifth Delivery to U.S.-Based EKOCUPS
-
Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20
-
Harsco Environmental Opens First SteelPhalt™ Plant Outside the UK
-
Integral Metals Commences Phase I Exploration at Woods Creek Project in Partnership with Big Rock Exploration
-
Dominion Lending Centres Inc. Announces Annual 2024 Earnings Release Date
-
REPEAT/MEDIA ADVISORY: Health Coalition to announce response to court rulings on Bill 7 Charter Challenge and Orchard Villa case
-
Wang & Lee Group, Inc. Announces Acquisition of Solar (HK) Limited, Paving the Way for Global Renewable Crypto Mining
-
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
-
Medallion Financial Corp. to Participate in Upcoming Investor Conference
-
Lotus Announces Strategic Partnership with CaoCao Mobility to Launch Intelligent Driving Platform for Robotaxis
-
Chanson International Holding Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Online Fraud is Surging, AI is the Weapon of Choice, Says Veriff's New Report
-
LiveOne (Nasdaq: LVO) to Participate in the 37th Annual ROTH Conference
-
Blum Holdings Inc. Reports Remarkable 2024 Financial Results with $33.1 Million in Net Income
-
Columbus Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on March 17, 2025
-
Brera Holdings and Global Law Firm Clifford Chance Release Report on Multi-Team Ownership of Women’s Soccer
-
Announcing Becklar Monitoring: SMART Critical Event Monitoring
-
Baker Hughes Announces Dates for First-quarter 2025 Earnings Release and Webcast
-
AllSurplus Conducts Second Sale in China for Global Energy Leader, Expanding Circular Economy Footprint
-
Southwire Taps Plug Power, Inc. to Advance Carbon Reduction from the Supply Chain
-
Redwood to Host Second Cross-Border Logistics Council Amid Trade Uncertainty
-
Oxbridge / SurancePlus to Attend Digital Asset Summit 2025 in New York
-
FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)
-
zSpace Set to Join Russell 2000® and 3000® Indexes
-
Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
-
Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
-
SUPERIOR GROUP OF COMPANIES TO PARTICIPATE IN THE SIDOTI MARCH INVESTOR CONFERENCE
-
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
-
OP Mortgage Bank's Report by the Board of Directors and Financial Statements as well as Corporate Governance Statement for 2024 published
-
OP Corporate Bank plc’s Report by the Board of Directors, Financial Statements and Corporate Governance Statement for 2024 published
-
OP Financial Group's Annual Report 2024 has been published
-
Municipality Finance will redeem early notes issued under its MTN programme
-
BIO-key Partners with California Ed Tech JPA to Make its Identity and Access Management Solutions Available to 195 Member Institutions Serving Over 2.6M Students
-
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
-
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
-
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
-
ZenaTech Expands ZenaDrone Team by 35 Engineers and Technicians to Meet Drone Production Manufacturing Capacity
-
Alliance Witan PLC - Net Asset Value
-
Advanced Flower Capital Inc. Announces Financial Results for Fourth Quarter and Full Year 2024
-
Altisource Announces Fourth Quarter and Full Year 2024 Financial Results
-
FTI Consulting Adds Regulatory Risk and Compliance Expert Michael Herde to Financial Services Offering
-
PDD Holdings to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025
-
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
